Skip to main content

Table 1 Baseline clinicopathologic variables of African American and Caucasian American patients and tumors utilized for BAC-based DNA copy number analysis and gene expression profiling

From: Copy number and gene expression differences between African American and Caucasian American prostate cancer

 

African American(n = 20)

Caucasian American(n = 21)*

Age (years)

  

   50-54

7 (35%)

5 (24%)

   55-59

6 (30%)

10 (48%)

   60-64

2 (10%)

3 (14%)

   ≥65

5 (25%)

3 (14%)

PSA

  

   Mean, SD

8.5, 3.5

8.3, 4.0

   Range

4-17

3-17

Stage

  

   II

12 (60%)

16 (76%)

   ≥III

8 (40%)

5 (24%)

Gleason score

  

   <7

3 (15%)

6 (29%)

   =7

16 (80%)

11 (52%)

   >7

1 (5%)

4 (19%)

  1. *41 tumors were utilized for BAC array (AA = 20, CA = 21); 33 of the 41 (AA = 19, CA = 14) were also utilized for gene expression.
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us